Tower Research Capital LLC (TRC) - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$64,992
-87.8%
1,492
-89.9%
0.00%
-88.9%
Q2 2023$533,640
+360467.6%
14,770
+270.3%
0.02%
+260.0%
Q1 2023$148
-72.0%
3,989
-65.9%
0.01%
-77.3%
Q4 2022$529
-99.9%
11,682
+92.3%
0.02%
+214.3%
Q3 2022$424,000
-57.3%
6,075
-58.9%
0.01%
-68.2%
Q2 2022$994,000
+35.1%
14,796
+65.3%
0.02%
+214.3%
Q1 2022$736,000
+151.2%
8,950
+348.4%
0.01%
+40.0%
Q4 2021$293,000
+33.8%
1,996
+61.0%
0.01%
-16.7%
Q3 2021$219,000
-67.6%
1,240
-70.3%
0.01%
-66.7%
Q2 2021$675,000
+70.5%
4,175
+80.4%
0.02%
+157.1%
Q1 2021$396,000
-40.9%
2,314
-24.1%
0.01%
-65.0%
Q4 2020$670,000
+20.9%
3,050
-8.7%
0.02%
+233.3%
Q3 2020$554,000
+103.7%
3,340
+40.2%
0.01%
-45.5%
Q2 2020$272,000
+13500.0%
2,383
+9432.0%
0.01%
Q1 2020$2,000
-97.6%
25
-96.1%
0.00%
-100.0%
Q4 2019$82,000
-26.8%
640
-55.5%
0.01%
-12.5%
Q3 2019$112,000
+30.2%
1,438
+23.1%
0.01%
+60.0%
Q1 2019$86,0001,168
+58300.0%
0.01%
Q4 2018$0
-100.0%
2
-99.6%
0.00%
-100.0%
Q3 2018$22,000
-68.6%
460
-79.7%
0.00%
-66.7%
Q1 2018$70,000
+150.0%
2,265
+44.1%
0.01%
+50.0%
Q4 2017$28,000
-54.8%
1,572
-90.6%
0.00%
-42.9%
Q2 2017$62,00016,793
+59875.0%
0.01%
Q1 2017$0
-100.0%
28
-99.2%
0.00%
-100.0%
Q4 2016$16,000
-88.1%
3,349
-83.4%
0.00%
-84.6%
Q3 2016$134,000
+252.6%
20,214
+189.8%
0.01%
+225.0%
Q2 2016$38,000
+245.5%
6,974
+1294.8%
0.00%
+100.0%
Q1 2016$11,000
+266.7%
500
+525.0%
0.00%
Q4 2015$3,000800.00%
Q3 2015$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2014$38,000
-61.2%
2,059
-63.2%
0.00%
-63.6%
Q3 2014$98,000
+292.0%
5,588
+353.6%
0.01%
+266.7%
Q2 2014$25,000
-51.9%
1,232
-54.0%
0.00%
-57.1%
Q1 2014$52,000
+67.7%
2,678
+41.6%
0.01%
+40.0%
Q4 2013$31,000
+520.0%
1,891
+530.3%
0.01%
+400.0%
Q3 2013$5,0003000.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders